Showing results (1-10 of 127) with videos related to
Sort By:
Pageof 13
Journal of Clinical Lipidology|September 27, 2012
Pseudohypertriglyceridemia: two cases of probable glycerol kinase deficiencyJames M Backes, Thomas Dayspring, Thomas Mieras, et al.Postgraduate Medicine|April 9, 2011
Important considerations for treatment with dietary supplement versus prescription niacin productsJames M Backes, Robert J Padley, Patrick M MoriartyThe Annals of Pharmacotherapy|January 27, 2004
Role of C-reactive protein in cardiovascular diseaseJames M Backes, Patricia A Howard, Patrick M MoriartyThe American Journal of Cardiology|July 31, 2007
Effects of once weekly rosuvastatin among patients with a prior statin intoleranceJames M Backes, Patrick M Moriarty, Janelle F Ruisinger, et al.Journal of Clinical Lipidology|April 11, 2017
Statin-associated muscle symptoms-Managing the highly intolerantJames M Backes, Janelle F Ruisinger, Cheryl A Gibson, et al.Journal of Clinical Lipidology|July 28, 2012
The high-dose rosuvastatin once weekly study (the HD-ROWS)James M Backes, Cheryl A Gibson, Janelle F Ruisinger, et al.Lipids|July 9, 2011
Modified-policosanol does not reduce plasma lipoproteins in hyperlipidemic patients when used alone or in combination with statin therapyJames M Backes, Cheryl A Gibson, Janelle F Ruisinger, et al.The Annals of Pharmacotherapy|November 19, 2009
Does simvastatin cause more myotoxicity compared with other statins?James M Backes, Patricia A Howard, Janelle F Ruisinger, et al.Pharmacotherapy|February 24, 2007
Fibrates: what have we learned in the past 40 years?James M Backes, Cheryl A Gibson, Janelle F Ruisinger, et al.The American Journal of Cardiology|January 27, 2009
Once-a-week rosuvastatin (2.5 to 20 mg) in patients with a previous statin intoleranceJanelle F Ruisinger, James M Backes, Cheryl A Gibson, et al.Pageof 13